Computational model of chimeric antigen receptor-engineered T cells

被引：0
|
作者：
Rohrs, Jennifer [1 ]
Wang, Pin [1 ]
Finley, Stacey D. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷 / 22期
关键词：
D O I：
10.1158/1538-7445.COMPSYSBIO-B2-33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B2-33
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy
    Bollino, Dominique
    Webb, Tonya J.
    TRANSLATIONAL RESEARCH, 2017, 187 : 32 - 43
  • [22] Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma Treatment
    Mihaila, Romeo G.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2019, 14 (04) : 312 - 323
  • [23] Chimeric antigen receptor-engineered T-cell therapy for liver cancer
    Chen, Yang
    Chang-Yong, E.
    Gong, Zhi-Wen
    Liu, Shui
    Wang, Zhen-Xiao
    Yang, Yong-Sheng
    Zhang, Xue-Wen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (04) : 301 - 309
  • [24] Chimeric antigen receptor-engineered T-cell therapy for liver cancer
    Yang Chen
    Chang-Yong E
    Zhi-Wen Gong
    Shui Liu
    Zhen-Xiao Wang
    Yong-Sheng Yang
    Xue-Wen Zhang
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (04) : 301 - 309
  • [25] Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy
    Siegler, Elizabeth Louise
    Wang, Pin
    HUMAN GENE THERAPY, 2018, 29 (05) : 534 - 546
  • [26] Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
    Shengmeng Di
    Zonghai Li
    Science China Life Sciences, 2016, 59 : 360 - 369
  • [27] Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells
    Alrifai, Doraid
    Sarker, Debashis
    Maher, John
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (01) : 50 - 60
  • [28] Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
    Di, Shengmeng
    Li, Zonghai
    SCIENCE CHINA-LIFE SCIENCES, 2016, 59 (04) : 360 - 369
  • [29] Adenosine Deaminase 1 Overexpression Enhances the Antitumor Efficacy of Chimeric Antigen Receptor-Engineered T Cells
    Qu, Yun
    Dunn, Zachary S.
    Chen, Xianhui
    MacMullan, Melanie
    Cinay, Gunce
    Wang, Hsuan-yao
    Liu, Jiangyue
    Hu, Fangheng
    Wang, Pin
    HUMAN GENE THERAPY, 2022, 33 (5-6) : 223 - 236
  • [30] Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects
    Shengmeng Di
    Zonghai Li
    Science China Life Sciences, 2016, (04) : 360 - 369
12345